Published in N Engl J Med on September 25, 2003
Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ (2005) 1.44
CT imaging in acute pulmonary embolism: diagnostic strategies. Eur Radiol (2005) 1.42
Document-level classification of CT pulmonary angiography reports based on an extension of the ConText algorithm. J Biomed Inform (2011) 1.20
How I treat venous thrombosis in children. Blood (2005) 1.17
Physicians' and midlevel providers' awareness of lifetime radiation-attributable cancer risk associated with commonly performed CT studies: relationship to practice behavior. AJR Am J Roentgenol (2012) 1.08
Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: a population-based cohort study in Ontario. PLoS Med (2010) 1.05
Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging (2005) 1.04
Triple rule-out CT in the emergency department: protocols and spectrum of imaging findings. Eur Radiol (2008) 0.99
Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes. J Nucl Med (2014) 0.85
Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats. J Nucl Med (2015) 0.84
Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J (2013) 0.82
CT pulmonary angiography: an over-utilized imaging modality in hospitalized patients with suspected pulmonary embolism. J Community Hosp Intern Med Perspect (2013) 0.82
When to perform CTA in patients suspected of PE? Eur Radiol (2007) 0.82
Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats. Arterioscler Thromb Vasc Biol (2015) 0.80
Computed tomography pulmonary angiography: a sample of experience at a District General Hospital. Ulster Med J (2008) 0.78
D-dimer in venous thromboembolism. N Engl J Med (2004) 0.78
Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy. Eur Heart J Acute Cardiovasc Care (2012) 0.78
An elevated D-dimer value: a burden on our patients and hospitals. Int J Gen Med (2012) 0.78
Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents. Thromb J (2014) 0.77
Predicting perioperative venous thromboembolism in Japanese gynecological patients. PLoS One (2014) 0.77
Assessment of lung function in children by cross-sectional imaging: techniques and clinical applications. Pediatr Radiol (2005) 0.77
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. Multidiscip Respir Med (2013) 0.77
D-dimer in venous thromboembolism. N Engl J Med (2004) 0.77
An analysis of patients that underwent computed tomography pulmonary angiography with the prediagnosis of pulmonary embolism in the emergency department. ScientificWorldJournal (2014) 0.77
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea. Open Access Emerg Med (2016) 0.77
Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging. Sci Rep (2016) 0.76
Advances in the diagnosis and treatment of acute pulmonary embolism. F1000 Med Rep (2012) 0.76
Suspected pulmonary embolism. N Engl J Med (2004) 0.75
Acute pulmonary embolism with electrocardiagraphic changes mimicking acute coronary syndrome: a case report and literature review. Int J Clin Exp Med (2015) 0.75
Suspected pulmonary embolism. N Engl J Med (2004) 0.75
Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report. J Athl Train (2013) 0.75
Suspected pulmonary embolism. N Engl J Med (2004) 0.75
Pulmonary Embolism Mortality in Brazil from 1989 to 2010: Gender and Regional Disparities. Arq Bras Cardiol (2015) 0.75
Study of clinical profile and management of patients with pulmonary embolism - single center study. Indian Heart J (2014) 0.75
Pediatric cardiac emergencies: Children are not small adults. J Emerg Trauma Shock (2011) 0.75
Detection of venous thromboembolism by proteomic serum biomarkers. PLoS One (2007) 0.75
The imaging diagnosis of pulmonary thromboembolism. Can Vet J (2009) 0.75
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med (2010) 5.79
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med (2008) 3.68
Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med (2007) 3.16
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol (2010) 2.55
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol (2005) 1.97
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol (2004) 1.92
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med (2006) 1.86
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest (2003) 1.71
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A (2005) 1.67
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67
End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.63
Outcome of lung transplantation in patients with mycetomas. Chest (2002) 1.59
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension. J Cardiovasc Pharmacol (2013) 1.55
Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol (2005) 1.42
SPECT in acute pulmonary embolism. J Nucl Med (2009) 1.40
Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension. J Cardiovasc Pharmacol (2016) 1.39
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol (2003) 1.37
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med (2005) 1.35
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol (2004) 1.24
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost (2010) 1.21
Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine. Int J Cardiovasc Imaging (2011) 1.17
Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III. Int J Cardiovasc Imaging (2011) 1.11
Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. Chest (2009) 1.11
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest (2013) 1.10
Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg (2005) 1.10
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant (2011) 1.09
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost (2005) 1.04
Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med (2002) 1.03
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg (2010) 1.02
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med (2008) 1.00
American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology (2012) 0.99
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol. J Rheumatol (2009) 0.97
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis (2011) 0.97
An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med (2011) 0.97
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther (2013) 0.94
Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest (2002) 0.94
Severe erythroderma as a complication of continuous epoprostenol therapy. Chest (2002) 0.93
Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension. Semin Respir Crit Care Med (2005) 0.92
D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism. AJR Am J Roentgenol (2009) 0.89
Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy. J Am Acad Dermatol (2004) 0.88
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med (2010) 0.87
Gender differences in the administration of prophylaxis to prevent deep venous thrombosis. Thromb Haemost (2005) 0.86
Diagnosis of pulmonary embolism in the coronary care unit. Am J Cardiol (2009) 0.85
Chronic thromboembolic pulmonary hypertension. Semin Thromb Hemost (2006) 0.85
High utilization rate of vena cava filters in deep vein thrombosis. Thromb Haemost (2005) 0.85
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. J Heart Lung Transplant (2007) 0.84
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J (2009) 0.83
One-year experience with intravenous treprostinil for pulmonary arterial hypertension. J Heart Lung Transplant (2013) 0.83
Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82
Lung transplantation and atrial septostomy in pulmonary arterial hypertension. Clin Chest Med (2013) 0.81
Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost (2010) 0.81
Venous thromboembolism in intensive care patients. Clin Chest Med (2003) 0.80
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis (2006) 0.80
Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. Am J Med (2012) 0.79
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study. Stroke (2012) 0.78
Road ahead to respiratory health: experts chart future research directions. Respirology (2009) 0.76
Diagnosing and managing acute pulmonary embolism: role of cardiac troponins. Am Heart J (2003) 0.76
The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. Am Heart J (2005) 0.76
Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel. J Vasc Interv Radiol (2005) 0.75
Clinical probability and D-dimer testing: how should we use them in clinical practice? Semin Respir Crit Care Med (2008) 0.75
Right ventricular responses to massive and submassive pulmonary embolism. Cardiol Clin (2012) 0.75
Managing pulmonary arterial hypertension and optimizing treatment options. Introduction. Am J Cardiol (2013) 0.75
Thrombolytic therapy for venous thromboembolism: current clinical practice. J Hosp Med (2009) 0.75
Few predictors of massive deep vein thrombosis. Thromb Haemost (2005) 0.75
The diagnosis of acute venous thromboembolism. Dis Mon (2005) 0.75
[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]. Presse Med (2011) 0.75
Commentary: Persistent gaps in VTE prophylaxis in orthopedic surgery: will new educational strategies help? Am J Med Qual (2011) 0.75
Protect your health in the air. Most people with chronic health conditions can travel by air safely--if they take a few precautions. Health News (2002) 0.75
[Treatment goals of pulmonary hypertension]. Turk Kardiyol Dern Ars (2014) 0.75
Prophylaxis for venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis (2011) 0.75
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial. Thromb Haemost (2013) 0.75